glp-1 reno receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Find the Best Medical Weight

FDA has warned about safety risks involving unapproved GLP-1 products used for weight loss

Interestingly, the inability of CD8 + T cells to deal with excessive intracellular ammonia, originating from glutaminolysis, leads to mitochondrial and lysosomal damage and cell death

Results Disclaimer

Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier

DutourAAbdesselamIAncelPKoberFMradGDarmonPet alExenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy